Stigma Reduction through Addiction and Naloxone Education

Murphy, Jennifer; Russell, Brenda L.

doi:10.1080/10511253.2022.2068632

Cited by 9 publications

(3 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…People experiencing addiction are often stigmatized in medical and behavioral health settings, even when providers know about stigma and actively try to address it (Henderson et al, 2008). Experiencing addiction-related stigma also leads to poorer treatment outcomes, greater mental health problems, and more reluctance to access addiction treatment services (Murphy & Russell, 2023). Unique to participants in the present study, stigmatizing experiences did not deter interest or motivation to seek ibogaine treatment.…”

Section: Discussionmentioning

confidence: 62%

Subjective ibogaine experiences across intersecting social-ecological dimensions

Ozmat,

McDonough,

Ladouceur

et al. 2024

JPS

View full text Add to dashboard Cite

Background and aimsIbogaine, an alkaloid extracted from the root of the Tabernanthe Iboga shrub, holds promise in treating addictive disorders. Individuals receiving ibogaine treatment report decreased withdrawal symptoms, cravings, and addiction severity. These changes are often attributed to ibogaine's psychedelic properties: subjectively meaningful, dream-like experiences. Research demonstrates that ibogaine experiences impact multiple social-ecological dimensions and influence addiction and recovery trajectories. No studies have explored the multidimensional experiences of individuals seeking ibogaine treatment for addictions. The current study examines acute and enduring ibogaine experiences at individual, interpersonal, and behavioral health systems levels.MethodsFifteen individuals (5 female, 10 male) who received ibogaine treatment at a medical clinic in Ensenada, Mexico completed semi-structured interviews asking about individual, interpersonal, and behavioral health system experiences post-ibogaine within 12 months of ibogaine treatment (Mdn = 169 days). Transcripts were coded and analyzed using a Consensual Qualitative Research approach.ResultsMany participants reported seeking ibogaine treatment after exhausting other addiction services. Outcomes reported following treatment included alleviated cravings and withdrawal symptoms. Participants indicated that ibogaine experiences prompted insight into their addictions and contributed to their recovery. Self-support and disclosing ibogaine experiences to professional and non-professional supporters were important to participants' recovery post-ibogaine.ConclusionsIntersecting experiences across social-ecological levels had an enduring impact on participants' addiction recovery after ibogaine treatment. Despite negative experiences with behavioral health systems prior to receiving ibogaine treatment, most participants sought the support of mental health professionals post-ibogaine. Findings are informative for mental health professionals and clients interested in ibogaine treatment.

show abstract

Section: Discussionmentioning

confidence: 62%

Subjective ibogaine experiences across intersecting social-ecological dimensions

Ozmat,

McDonough,

Ladouceur

et al. 2024

JPS

View full text Add to dashboard Cite

show abstract

“…24 Cezaevinde çalışan psikoloji öğrencilerine verilen 3 saatlik bağımlılık ve nalokson kullanımı eğitimi sonrası katılımcıların damgalama anket puanlarında düşüş olduğu gösterilmiştir. 25 Damgalamanın etkisi sadece alkol madde kullanımı olan birey ile sınırlı kalmaz. Damgalama bağımlı bireyin ailesini ve yakın sosyal çevresini de olumsuz yönde etkiler.…”

Section: Discussionunclassified

Pediatri Hekimlerinin Bağımlı Hastaları Damgalama Düzeylerine Bağımlılık Eğitiminin Etkisi

KARDAŞ,

GÜMÜŞSOY,

TANIR

et al. 2023

Acta Medica Nicomedia

View full text Add to dashboard Cite

Amaç: Ruhsal hastalıklar arasında en sık damgalanan hastalar bağımlı bireylerdir. Bağımlılıkta damgalama; daha kötü prognoz, daha sık relaps, daha az tedavi başvurusuyla ilişkilendirilmiştir. Bu nedenle bu çalışmada pediatri hekimlerinin bağımlılık ile ilgili damgalama düzeyinin ölçülmesi, bu hekimlere verilecek eğitimin damgalama düzeyine etkisi araştırılmıştır. Yöntem: Pediatri anabilim dalı’nda çalışan hekimlere “Bağımlı Ergene Yaklaşım” adlı seminer verilmiştir. Katılımcılara, sosyodemografik bilgiler ile kullanılması planlanan “Yedam Madde Bağımlılığı Stigmatizasyon Ölçeği (YMSÖ)” maddelerinin yer aldığı form tek sayfa halinde eğitim öncesinde ve sonrasında uygulanarak analiz edilmiştir. Bulgular: Örneklemin 18 (%69,2)’i kadın, 8 (%30,8)’i erkek, yaş ortalaması 37,8±11,6’di. Tüm örneklemin YMSÖ ortalama puanı eğitim öncesi 17,7±5,1, eğitim sonrası 16±5,3 olarak saptanmıştır. Bu değişim istatistiksel olarak anlamlıydı (p

show abstract

“…This can also lead to fear to disclose their recovery status, and the desire to maintain secrecy can reduce their likelihood of seeking or continuing treatment (Burgess et al, 2021; Earnshaw et al, 2019). However, there is some evidence that educating health care professionals and the public about SUDs from the perspective of individuals in recovery who have lived experience can help reduce stigma (Bakos-Block et al, 2022; Bielenberg et al, 2021; Murphy & Russell, 2023).…”

Section: The Present Studymentioning

confidence: 99%

Identifying the trajectory of public stigma across the stages of recovery from a substance use disorder.

Zurawel,

Lacasse,

Spas

et al. 2024

Stigma and Health

View full text Add to dashboard Cite

Stigma felt by those with substance use disorders (SUDs) is both well documented and often a barrier to seeking treatment. This research was designed to better understand how stigma may change as people enter recovery and to document the trajectory of public stigma toward those in the three stages of recovery from a SUD (i.e., early, sustained, long-term). Participants (N = 185) were randomly assigned to read one of five brief vignettes about the life events a person who (1) had no history of a SUD, (2) was currently using heroin, or was in (3) early recovery-6 months, (4) sustained recovery-2 years, or (5) long-term recovery-5 years. Findings from this study revealed that public stigmatization is frequently lower for those in recovery from a SUD than for those currently using and that stigma is similar across all three stages of recovery. Several factors of public stigma (i.e., bad character traits, support of discrimination) were less-strongly endorsed across all recovery stages, while endorsement of other stigma factors (i.e., perceptions of worthlessness or criminality) was higher in early recovery than in long-term recovery. Alternately, endorsement of good character traits and hopeful emotional reactions was quite high in early recovery and beyond. Obtaining a better understanding of how public stigmatization changes when directed at individuals at different stages of SUD recovery can help focus efforts on decreasing the remaining stigma. Clinical Impact StatementThe public applies less stigma and has more positive reactions to people in recovery from a substance use disorder than to those currently using drugs. The stigma is often similarly low regardless of how long someone has been in recovery, but certain stigmatizing attributes are still attached to those in early recovery more than to those in long-term recovery. More public education about what it means to be in recovery could lead to the public gaining an overall better understanding of this population and, ultimately, toward reducing the remaining stigma attached to those in recovery from a substance use disorder.

show abstract

Stigma Reduction through Addiction and Naloxone Education

Cited by 9 publications

References 42 publications

Subjective ibogaine experiences across intersecting social-ecological dimensions

Subjective ibogaine experiences across intersecting social-ecological dimensions

Pediatri Hekimlerinin Bağımlı Hastaları Damgalama Düzeylerine Bağımlılık Eğitiminin Etkisi

Identifying the trajectory of public stigma across the stages of recovery from a substance use disorder.

Contact Info

Product

Resources

About